Literature DB >> 29672770

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair.

Tomoko Kato-Inui1, Gou Takahashi1, Szuyin Hsu1, Yuichiro Miyaoka1.   

Abstract

Genome editing using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) predominantly induces non-homologous end joining (NHEJ), which generates random insertions or deletions, whereas homology-directed repair (HDR), which generates precise recombination products, is useful for wider applications. However, the factors that determine the ratio of HDR to NHEJ products after CRISPR/Cas9 editing remain unclear, and methods by which the proportion of HDR products can be increased have not yet been fully established. We systematically analyzed the HDR and NHEJ products after genome editing using various modified guide RNAs (gRNAs) and Cas9 variants with an enhanced conformational checkpoint to improve the fidelity at endogenous gene loci in HEK293T cells and HeLa cells. We found that these modified gRNAs and Cas9 variants were able to enhance HDR in both single-nucleotide substitutions and a multi-kb DNA fragment insertion. Our results suggest that the original CRISPR/Cas9 system from the bacterial immune system is not necessarily the best option for the induction of HDR in genome editing and indicate that the modulation of the kinetics of conformational checkpoints of Cas9 can optimize the HDR/NHEJ ratio.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29672770      PMCID: PMC5961419          DOI: 10.1093/nar/gky264

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

Review 1.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

2.  Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells.

Authors:  Daesik Kim; Sangsu Bae; Jeongbin Park; Eunji Kim; Seokjoong Kim; Hye Ryeong Yu; Jinha Hwang; Jong-Il Kim; Jin-Soo Kim
Journal:  Nat Methods       Date:  2015-02-09       Impact factor: 28.547

3.  Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection.

Authors:  Lin Ye; Jiaming Wang; Ashley I Beyer; Fernando Teque; Thomas J Cradick; Zhongxia Qi; Judy C Chang; Gang Bao; Marcus O Muench; Jingwei Yu; Jay A Levy; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

4.  Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.

Authors:  Van Trung Chu; Timm Weber; Benedikt Wefers; Wolfgang Wurst; Sandrine Sander; Klaus Rajewsky; Ralf Kühn
Journal:  Nat Biotechnol       Date:  2015-03-24       Impact factor: 54.908

5.  Crystal structure of Cas9 in complex with guide RNA and target DNA.

Authors:  Hiroshi Nishimasu; F Ann Ran; Patrick D Hsu; Silvana Konermann; Soraya I Shehata; Naoshi Dohmae; Ryuichiro Ishitani; Feng Zhang; Osamu Nureki
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

6.  Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.

Authors:  Seung Woo Cho; Sojung Kim; Yongsub Kim; Jiyeon Kweon; Heon Seok Kim; Sangsu Bae; Jin-Soo Kim
Journal:  Genome Res       Date:  2013-11-19       Impact factor: 9.043

7.  Isolation of single-base genome-edited human iPS cells without antibiotic selection.

Authors:  Yuichiro Miyaoka; Amanda H Chan; Luke M Judge; Jennie Yoo; Miller Huang; Trieu D Nguyen; Paweena P Lizarraga; Po-Lin So; Bruce R Conklin
Journal:  Nat Methods       Date:  2014-02-09       Impact factor: 28.547

8.  Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.

Authors:  Takeshi Maruyama; Stephanie K Dougan; Matthias C Truttmann; Angelina M Bilate; Jessica R Ingram; Hidde L Ploegh
Journal:  Nat Biotechnol       Date:  2015-03-23       Impact factor: 54.908

9.  Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.

Authors:  Janice S Chen; Yavuz S Dagdas; Benjamin P Kleinstiver; Moira M Welch; Alexander A Sousa; Lucas B Harrington; Samuel H Sternberg; J Keith Joung; Ahmet Yildiz; Jennifer A Doudna
Journal:  Nature       Date:  2017-09-20       Impact factor: 49.962

10.  CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients.

Authors:  Shu Su; Bian Hu; Jie Shao; Bin Shen; Juan Du; Yinan Du; Jiankui Zhou; Lixia Yu; Lianru Zhang; Fangjun Chen; Huizi Sha; Lei Cheng; Fanyan Meng; Zhengyun Zou; Xingxu Huang; Baorui Liu
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

View more
  14 in total

Review 1.  The role of micropeptides in biology.

Authors:  Rui Vitorino; Sofia Guedes; Francisco Amado; Manuel Santos; Nobuyoshi Akimitsu
Journal:  Cell Mol Life Sci       Date:  2021-01-28       Impact factor: 9.261

Review 2.  CRISPR-Cas technology based genome editing for modification of salinity stress tolerance responses in rice (Oryza sativa L.).

Authors:  Ibrahim Khan; Sikandar Khan; Yong Zhang; Jianping Zhou; Maryam Akhoundian; Sohail Ahmad Jan
Journal:  Mol Biol Rep       Date:  2021-05-05       Impact factor: 2.316

Review 3.  Genome Editing Targets for Improving Nutrient Use Efficiency and Nutrient Stress Adaptation.

Authors:  Lekshmy Sathee; B Jagadhesan; Pratheek H Pandesha; Dipankar Barman; Sandeep Adavi B; Shivani Nagar; G K Krishna; Shailesh Tripathi; Shailendra K Jha; Viswanathan Chinnusamy
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

4.  Single molecule analysis of effects of non-canonical guide RNAs and specificity-enhancing mutations on Cas9-induced DNA unwinding.

Authors:  Ikenna C Okafor; Digvijay Singh; Yanbo Wang; Minhee Jung; Haobo Wang; John Mallon; Scott Bailey; Jungjoon K Lee; Taekjip Ha
Journal:  Nucleic Acids Res       Date:  2019-12-16       Impact factor: 16.971

5.  Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons.

Authors:  Christa Überbacher; Julia Obergasteiger; Mattia Volta; Serena Venezia; Stefan Müller; Isabella Pesce; Sara Pizzi; Giulia Lamonaca; Anne Picard; Giada Cattelan; Giorgio Malpeli; Michele Zoli; Dayne Beccano-Kelly; Rowan Flynn; Richard Wade-Martins; Peter P Pramstaller; Andrew A Hicks; Sally A Cowley; Corrado Corti
Journal:  Stem Cell Res       Date:  2019-11-09       Impact factor: 2.020

6.  High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells.

Authors:  Alewo Idoko-Akoh; Lorna Taylor; Helen M Sang; Michael J McGrew
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

Review 7.  Application of CRISPR genetic screens to investigate neurological diseases.

Authors:  Raphaella W L So; Sai Wai Chung; Heather H C Lau; Jeremy J Watts; Erin Gaudette; Zaid A M Al-Azzawi; Jossana Bishay; Lilian Tsai-Wei Lin; Julia Joung; Xinzhu Wang; Gerold Schmitt-Ulms
Journal:  Mol Neurodegener       Date:  2019-11-14       Impact factor: 14.195

Review 8.  DGK and DZHK position paper on genome editing: basic science applications and future perspective.

Authors:  Ralf P Brandes; Anne Dueck; Stefan Engelhardt; Manuel Kaulich; Christian Kupatt; Maria Teresa De Angelis; Matthias S Leisegang; Ferdinand le Noble; Alessandra Moretti; Oliver J Müller; Boris V Skryabin; Thomas Thum; Wolfgang Wurst
Journal:  Basic Res Cardiol       Date:  2021-01-15       Impact factor: 17.165

9.  Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles.

Authors:  Carla Sanjurjo-Soriano; Nejla Erkilic; David Baux; Daria Mamaeva; Christian P Hamel; Isabelle Meunier; Anne-Françoise Roux; Vasiliki Kalatzis
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-27       Impact factor: 6.698

Review 10.  Genome Editing for CNS Disorders.

Authors:  Fábio Duarte; Nicole Déglon
Journal:  Front Neurosci       Date:  2020-10-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.